TGFB1 and colorectal cancer: This analysis validated that mutations in the RTK-RAS (effect size = 0.74; FDR = 0.034) and TGF-Beta (effect size = 0.67; FDR < 0.001) pathways were associated with PM in colorectal cancer (Fig. 5b, Supplementary Data 11).